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Abstract
Background: Chinese hamster ovary (CHO) cells have become the host of choice for the production of recombinant
proteins, due to their capacity for correct protein folding, assembly, and posttranslational modifications. The most
widely used system for recombinant proteins is the gene amplification procedure that uses the CHO-Dhfr expression
system. However, CHO cells are known to have a very unstable karyotype. This is due to chromosome rearrangements
that can arise from translocations and homologous recombination, especially when cells with the CHO-Dhfr expression
system are treated with methotrexate hydrate. The present method used in the industry for testing clones for their
long-term stability of recombinant protein production is empirical, and it involves their cultivation over extended
periods of time prior to the selection of the most suitable clone for further bioprocess development. The aim of the
present study was the identification of marker genes that can predict stable expression of recombinant genes in
particular clones early in the development stage.
Results: The transcriptome profiles of CHO clones with stable and unstable recombinant protein production were
investigated over 10-weeks of cultivation, using a DNA microarray. We identified 14 genes that were differentially
expressed between the stable and unstable clones already at 2 weeks from the beginning of the cultivation. Their
expression was validated by reverse-transcription quantitative real-time PCR (RT-qPCR). Furthermore, the k-nearest
neighbour algorithm approach shows that the combination of the gene expression patterns of only five of these 14
genes is sufficient to predict stable recombinant protein production in clones in the early phases of cell-line
development.
Conclusions: The exact molecular mechanisms that cause unstable recombinant protein production are not fully
understood. However, the expression profiles of some genes in clones with stable and unstable recombinant protein
production allow prediction of such instability early in the cell-line development stage. We have thus developed a
proof-of-concept for a novel approach to eliminate unstable clones in the CHO-Dhfr expression system, which saves
time and labour-intensive work in cell-line development.
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Background
The production of recombinant proteins using mamma-
lian cells is a large industry today, which accounts for
billions of dollars annually for the production of biother-
apeutic products [1]. Chinese hamster ovary (CHO) cells
have become the host of choice for recombinant protein
production, due to their capacity for correct protein
folding, assembly and posttranslational modification.
Moreover, CHO cell lines have been well characterised,
and they have a very well-known history of regulatory
approval for recombinant protein production [2, 3]. The
CHO-Dhfr expression system is the most widely used
for high-level expression of recombinant products in
CHO cell lines [1–3].
However, CHO cells are known to have a very unstable
karyotype, due to chromosome rearrangements that can
arise from translocations and homologous recombination,
especially when amplified with methotrexate hydrate
(MTX) [4, 5]. In this context, unstable recombinant pro-
tein production has been observed in 8 to 63 % of all re-
combinant CHO (rCHO) cell lines using CHO-Dhfr/
glutamine synthetase expression systems in the absence
and presence of selection pressure (MTX) [6–8]. When
the cells are propagated in the absence of a selective agent,
the amplified genes can be maintained or lost [9]. Changes
in the rCHO cell populations after extended cultivation in
the absence and presence of selective pressure have been
reported [10, 11]. Fann and colleagues reported unstable
recombinant protein production in rCHO cell populations
in the presence of MTX, but not to the same extent as
when the selective pressure was absent [11]. Previous
microarray expression profiling studies have been focused
mainly on improved mechanisms underlying high cell
productivity [12–16]. Trummer and colleagues identi-
fied potential marker genes related to productivity
and stress resistance [16]. Some productivity oriented
studies have included transcriptomics and/or prote-
omic studies [17–22].
In the present study, the transcriptome profiles of
CHO clones with stable and unstable recombinant pro-
tein production were investigated over a 10-week period.
The main purpose of the present study was to identify
marker genes that can predict stable recombinant pro-
tein production in early cell-line development.
Results and discussion
One of the problems still associated with recombinant
protein production using the standard approach of clone
screening is, however, the large percentage of clones
with unstable productivity of the recombinant protein,
which limits rapid and efficient cell-line development.
To identify early marker genes for stable recombinant
protein production in clones, the transcriptome profiles of
the stable and unstable CHO cell clones over a 10-week
period were investigated, with two sampling points in the
beginning (weeks 1, 2) and two sampling points at the end
(weeks 9, 10) of the study period.
Clone productivity, recombinant gene expression, and
copy number in the 10-week study
This study was performed on six transfected clones. All
six of these clones were grown with MTX in the media
before the stability study began, to enhance the productiv-
ity of the clones. At the beginning of the stability study,
each of these six clones was split and further grown with-
out and with MTX in the media. The ‘Beginning’ refers to
the beginning of the stability study. The sampling at weeks
1 and 2 contains data from the six clones (each grown
without and with MTX in the media), which resulted
in 24 samples. Similarly, 24 samples were collected in
weeks 9 and 10, and these are referred to as the ‘End’
samples (Fig. 1).
To define the phenotypes of all six of these clones, we
measured the productivity and recombinant gene copy
numbers for all of the samples at each time point. Thus,
the productivity and recombinant gene copy numbers
were calculated from the samples grown without MTX
(12 samples) and with MTX (12 samples) in the media,
from the “Beginning” (2 sampling: at week 1 and week
2), giving 24 samples altogether and similarly at the End
(2 sampling: at week 9 and week 10) of the stability
study. Two groups of samples were formed at the end of
the study, as stable samples (End-stable samples) and
unstable samples (End-unstable samples). The relation-
ship between the productivity and the recombinant gene
copy number is shown in Fig. 2.
All of the six clones were cultivated in parallel without
and with MTX, and therefore we could observe the influ-
ence of MTX on the stability of the recombinant protein
production. All six of the clones cultivated with MTX in
the media were identified as stable producing clones,
while the initially high-producing clones cultivated with-
out MTX in the media showed unstable recombinant pro-
tein production. The stable producing clones varied on
average by 9 % (7.1 to 6.4 arbitrary units) in their initial
productivity over the period of 10 weeks. In contrast, the
productivity in the unstable clones declined on average by
67 % (7.1 to 2.3 arbitrary units) over the same period. The
decline in recombinant gene copy numbers in the stable
high-producing clones in the same period was 45 % (5.4
to 3.0 recombinant gene copies per cell), compared to a
61 % decline (5.4 to 2.1 recombinant gene copies per cell)
in the unstable clones (Fig. 2).
The unstable recombinant protein production of the
CHO-Dhfr expression system used in this study over
long-term cultivation without selection pressure is at-
tributed to a decrease in the recombinant gene copies
[23]. A relation between the decline of recombinant
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protein productivity and the decline of recombinant
gene copy numbers over long-term cultivation was also
observed in the present study (Fig. 2). It is common for
productivity to drop by up to 71 % when selection pressure
is not present in the media, as described by Chusainow
[23]. It has been additionally reported that cell lines can
lose productivity during cultivation in the absence of se-
lective pressure via transcriptional silencing by methyla-
tion, with no loss in recombinant gene copies [24–26].
Promoter methylation is generally known to cause gene si-
lencing, and has recently been shown to additional con-
tribute to unstable recombinant protein production in
CHO cell lines expressing an IgG [26]; however, such ef-
fects were not prominent in the present study.
Transcriptional analysis of the stable and unstable clones
Altogether 48 samples (24 stable and 24 unstable samples)
were collected and further analysed using a whole-genome
DNA microarray and RT-qPCR. The transcript profiles of
the stable and unstable clones over their 10-week cultiva-
tion were analysed using a whole-genome DNA microarray
(Additional file 1). By comparing the transcriptome profile
of stable and unstable groups of clones, 295 differently
expressed genes were identified (with corrected P value
<0.05). As the productivity results for all of the unstable
clones were obtained when selection pressure was not
present (i.e., without MTX in the media), we have com-
pared these results with the effects of cultivating cells with-
out or with MTX. In all, 199 genes were identified as
differentially expressed between the group of clones culti-
vated without and with MTX in the media (with corrected
P value <0.05) and 83 genes were common to both ana-
lyses. The remaining 212 genes were specifically differen-
tially expressed when comparing the stable and unstable
clones, and were therefore the focus of our further study.
The expression profiles of the 14 top differentially
expressed genes between the stable and unstable clones
(where an additional cut-off for a strong fold-change in
expression was applied, as: logFCabs >0.8) was verified
(Additional file 2) using RT-qPCR. These genes were:
Fgfr2, BX842664.2/Hist1h3c, AC115880.11, E130203b14,
hDhfr, Hist1h2bc, Cspg4, C1qtnq, Foxp2, Mmp10, Vsnl1,
CU459186.17, Egr1 and Ptpre (Additional file 3). Among
these genes, E130203B14, BX842664.2/Hist1h3c, Ptpre,
Cspg4, Fgfr2 and Vsnl1 were identified as not affected by
the presence of MTX in the media. Statistical analysis of
Fig. 1 Set-up of the experiment. The study was performed on six transfected clones. Before the stability study began, all six of these clones were grown
with MTX in the media to enhance the productivity of the clones. At the beginning of the study, all of the six clones were split and further grown without
and with MTX in the media. ‘Beginning’ refers to the beginning of the stability study (sampling at weeks 1, 2) and contains data from the six clones grown
without and with MTX in the media, giving 24 samples. Similarly, 24 samples were collected in weeks 9 and 10, and are referred to as the ‘End’ samples
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the RT-qPCR data comparing the clones that showed
stable and unstable recombinant production regardless
of the sampling times confirmed differential expression
for 13 out of these 14 genes (with corrected P value
<0.05) (Fig. 3). The Vsnl1 gene was the only gene that
was not expressed differentially between the stable and
unstable clones (with corrected P = 0.22) after the RT-
qPCR analysis. Seven of the 14 genes tested were up-
regulated (Fgfr2, BX842664.2/Hist1h3c, AC115880.11,
hDhfr, Hist1h2bc, Mmp10, CU459186.17), and six were
down-regulated (E130203b14, Cspg4, C1qtnq, Foxp2,
Egr1, Ptpre) (Fig. 3). The greatest differences in gene ex-
pression among these genes specifically for the compari-
son between stable and unstable clones were observed
for the BX842664.2/Hist1h3c, Ptpre and Fgfr2 genes.
Potential marker genes that predict stable recombinant
protein production in the early phases of cell-line
development
The main purpose of the present study was to identify
marker genes in the early phases of cell-line development
that can be used to predict stable recombinant protein
production. Thus, we only used the data from the samples
collected at the beginning of the study (i.e., ‘Beginning’),
without or with MTX in the media, to determine whether
their expression profiles could be used to separate them
into stable and unstable clones as determined at the end
of the study (i.e., ‘End’). Five genes (E130203B14,
BX842664.2/Hist1h3c, Ptpre, Cspg4, Fgfr2) were selected
for this analysis from among these 13 differentially
expressed genes because the expression of these genes
was shown not to be affected by the presence of MTX in
the media and all five genes were differently expressed be-
tween stable and unstable samples. Three out of the 24
samples used here did not pass our quality control criteria
for reliable quantification by RT-qPCR for all of these five
genes, and these were thus excluded from analysis. Princi-
pal component analysis (PCA) of the expression of these
five genes shows that more than 92 % of the total
variability of the gene expression data can be ex-
plained by the first three principal components. When
the first three principal components were presented
Fig. 2 Correlation between the productivity and recombinant gene copy numbers in the clones. The productivity and recombinant gene copy
numbers of the clones are represented according to the ‘Beginning’ (weeks 1, 2) and at the ‘End’ (weeks 9, 10) of the 10-week study, as indicated.
At the Beginning, when the clones were split for parallel growth without MTX in the media, there were no large differences in the productivity
and copy numbers between the clones grown without and with MTX in the media. Due to high biological similarity of several (5) samples at the
“Beginning”, some of the data are overlapping, and therefore not all 24 data points are visible
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in three-dimensional form (Fig. 4), there was clear separ-
ation of the stable and unstable clones. The classification
with the k-nearest neighbour algorithm also confirmed
the separation of the two groups. For the Beginning data
(i.e., those originating at the beginning of the study), the
optimal number of clusters is four where the unstable
clones form a distinct cluster. Even for a sub-optimal
number of clusters (three and five clusters), the un-
stable clones form a separate cluster, which suggests
that unstable clones form a very compact and distinct-
ive cluster. By observing the sample grouping in Fig. 4,
it is evident that the data can be grouped into several
clusters with the unstable clones as a separate cluster.
Numerous approaches have been addressed to predict
stable recombinant protein production in early cell-line
development. For example, Dorai and colleagues [27]
identified apoptosis as a possible cause of instability
using a flow cytometry method for the identification of
apoptotic cells in early cell-line development (i.e.,
caspase-3 activity). Barnes and colleagues [28] indicated
that the levels of recombinant mRNA expression de-
tected by Northern blotting related to stable recombin-
ant protein production at the beginning of long-term
cell culture. A whole transcriptome marker identification
approach as described in the present study has not been
described previously.
Putative functional correlations of potential marker genes
with stable recombinant protein production
Genes Fgfr2 and Egr1 of the identified potential markers
of instability have functions related to cell growth [29–32],
genes hDhfr, Hist1h2bc and BX842664.2/Hist1h3c are in-
volved in DNA replication and chromosomal stability
[33–36]. The following two genes Cspg4 and protease
Mmp10 are important in cell migration and cell regulation
[37–42]. Another group of potential marker genes (Ptpre
and Vsnl1) is involved in intracellular signaling [43–47].
Genes Foxp2 and Ac115880.11 are regulators of transcrip-
tion [48–50] and C1qtnf1 is involved in regulation of gene
Fig. 3 Box plot of the relative gene expression ratios for the stable (S) and unstable (US) clones. The relative gene expression ratios for Fgfr2,
BX842664.2/Hist1h3c, AC115880.11, hDhfr, Hist1h2bc, Mmp10, CU459186.17, E130203b14, Cspg4, C1qtnq, Foxp2, Egr1 and Ptpre (log2FC) for the stable
(S) and unstable (UN) clones are shown. The relative expression values were normalised using the geometric mean of the reference genes Actb/
Gapdh. The threshold for statistical significance between the relative expression ratios of the stable and unstable clones was set to P = 0.05
(Welch two tailed t-tests). Box plots for genes where such differences were observed are represented in dark grey, in contrast to the white
boxplots for non-significant genes
Fig. 4 Three-dimensional representation based on principal
component analysis. The properties of the clones are described
according to the first three principal components (P1, P2, P3) of the
expression of the genes E130203B14, BX842664.2/Hist1h3c, Ptpre,
Cspg4 and Fgfr2
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expression [51–53]. All (but Foxp2 and Ac115880.11)
were already implied in relation to cancerogenesis show-
ing the potential link of identified genes to instability of
cellular processes in mammals. No functions for genes
E130203b14 and Cu459186.17 have been described to
date.
Conclusions
The precise molecular mechanisms behind genetically
unstable transgene expression are not fully understood.
However, some gene expression properties between
clones with stable and unstable recombinant production
can be used to predict this instability. By combining the
expression patterns of the E130203B14, BX842664.2/
Hist1h3c, Ptpre, Cspg4 and Fgfr2 genes using principal
component analysis, clear separation of the stable and
unstable clones can be achieved through observing just
the first three most significant principal components.
Based on this analysis, the unstable clones in our setting
can already be excluded in the early stage of such cell-
line development. In this way, a lot of labour-intensive
work, and in particular a lot of time, can be saved in the
development of such cell lines. However, potential
marker genes were identified for a limited number of
clones, and thus this approach needs to be tested further
to be fully implemented as a replacement for the stand-
ard methods of screening stability.
Methods
Cell line development
The CHO-der cell line was originally purchased from
the European Collection of Cell Cultures (ECACC). The
CHO-der1 cell line used in the present study was devel-
oped from the CHO-der cell line without any genetic
modifications, at Sandoz (Cell and Molecular Biology
Department, Slovenia). It was adapted for in-house
serum-free media and for better growth performance.
The expression vector was constructed in GeneArt
(Life Technologies), and it consisted of the recombinant
gene plus the antibiotic resistance and recombinant Dhfr
(rDhfr) gene. The linearised expression vector was trans-
fected to the host CHO cell line using the nucleofection
programme for CHO cells (Nucleofector, Lonza), ac-
cording to the manufacturer protocol. After transfection,
antibiotic selection was performed, followed by amplifi-
cation of the recombinant gene by MTX. The cloning
was performed using ClonePix FL technology (Molecular
Devices).
Experimental set-up
Six high-producing clones were selected for this study. All
of these six clones were grown in two parallel settings:
without MTX in the media, and with MTX in the media.
The in-house serum-free media was supplemented with
L-glutamine and was used for all of these cultures. The
cultures were propagated in suspension and diluted to
achieve initial cell concentrations of 2.0–3.0 × 105 cells/ml.
The cells were cultivated for 10 weeks, with passages per-
formed twice per week. The samples for RNA and DNA
isolation were taken on day 3 (at mid-log phase) of weeks
1, 2, 9 and 10. In all 48 samples were collected in the study
(6 clones grown without and with MTX in the media),
each sample originating from 4 data points (weeks 1, 2, 9
and 10). The cells were counted during the passages twice
per week using Vicell (Beckman Coulter). To measure the
productivity, batches were started from each clone on
weeks 1, 2, 9 and 10. The productivity was measured by
Octet (Forte Bio), which uses the bio-layer interferometry
technology for monitoring the binding of proteins to their
partners directly in real time. To confirm that the clones
under investigation varied only in terms of the absence
and presence of MTX, the cultures were cultivated in par-
allel under the same conditions (37 °C, 10 % CO2, 30 ml
working volume, in shaking flasks).
RNA and DNA isolation
The total RNA was isolated using the automated QiaCube
(Qiagen) system with RNeasy mini kits (Qiagen), following
the manufacturer protocol. The total RNA was examined
using an spectrophotometer (ND-1000; NanoDrop Tech-
nologies), with the total RNA integrity monitored using an
RNA nano-chip on a Bioanalyser 2100 (Agilent). The
same total RNA was used for the DNA microarray and for
the RT-qPCR analysis. An additional step of genomic
DNA removal using DNase I (Ambion) was performed
prior to the cDNA synthesis. After the DNase I treatment,
the RNA was transcribed into cDNA using SuperScript
VILO kits (Invitrogen), according to the manufacturer
protocol. The genomic DNA (gDNA) from the samples
was isolated using DNA Blood kits (Qiagen), with an auto-
mated system for DNA isolation (QiaCube, Qiagen), ac-
cording to the manufacturer protocol. The gDNA was
quantified using spectrophotometer (ND-1000; NanoDrop
Technologies).
Microarray hybridisation
The proprietary CHO-specific DNA microarray (Affyme-
trix) used in this study consisted of 61,223 probe sets,
which targeted approximately 26,227 Chinese hamster
unique gene IDs, and 14,657 unique Ensembl mouse
genes. Before being hybridised to the microarray, all of the
mRNA samples were diluted to the same concentration
(50 ng/μl). Biotinylated cRNA was prepared according to
the protocol described in the Affymetrix technical manual.
The subsequent hybridisation was performed in a Gene-
Chip Hybridisation oven 640 (Affymetrix), and the pro-
cessing was carried out using a GeneChip Fluidics station
450 (Affymetrix).
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Microarray data processing and analysis
The studied clones from all four data points (week 1, 2 –
‘Beginning’ and week 9, 10 – ‘End’) were divided into two
main groups: clones with stable recombinant protein pro-
duction (24 stable clones from all data points), and clones
with unstable recombinant protein production (24 unstable
clones from all data points). The clones were classi-
fied here as unstable if there was a decrease in their
productivity of >30 % and if the transgene copy number
dropped by >50 % over the study period of 10 weeks.
The raw image files were processed using the GeneSpring
GX software (Agilent Technologies), and normalised using
the robust multichip average algorithm [54–56]. All of the
further statistical analysis was performed in the Bioconduc-
tor using the limma package [57, 58]. To reduce the extent
of false positive results, the non-expressed genes were fil-
tered out (i.e., those with expression value below back-
ground in at least 80 % of all samples). Empirical Bayes
modelling that took into account the stability and the
presence of MTX was used to detect differentially
expressed genes between the different clones ([59]; for
corrected P ≤0.1). Only 524 probes (out of 61,223
probes) were used for the further analysis. The number
of transcripts were further reduced to 14 genes (logF-
Cabs >0.8; for corrected P <0.05).
Quantitative real-time qPCR
Based on DNA microarray data, 14 genes that were dif-
ferentially expressed between the stable and unstable
clones were chosen for further verification using RT-
qPCR. The primer pairs and probes were designed in the
region of the microarray oligo design, to ensure com-
patibility of the data between both of the platforms. The
TaqMan-MGB® probes for all of the genes were designed
and manufactured as Custom TaqMan Gene Expression
Assays, by Life Technologies. For relative expression cal-
culations, two reference genes were used (Actb, Gapdh).
The primers and probes used for the assays (i.e., gene ex-
pression and copy number) are listed in detail in Tables 1
and 2. The QIAgility automated liquid-handling system
(Qiagen) was used to prepare two cDNA dilutions (30×,
300×) per sample, and to pipette the cDNA samples and
master mix into the 384-well plates. The optimal dilution
factors were determined individually for each amplicon on
a subset of samples, for the quantification cycle (Cq)
values to be in the range of 22–34. All of the RT-qPCR re-
actions were performed in triplicate on an ABI PRISM®
7900 Sequence Detection system (Life Technologies), in
384-well plate format using universal cycling conditions.
Each sample was analysed as two dilutions and three repli-
cates per dilution step. The only samples used for the rela-
tive quantification where those where the ΔCq between
the two dilutions of the target gene did not deviate by
more than 0.5 from ΔCq of the reference gene.
RT-qPCR data processing and statistical analysis
The SDS 2.1 software (Life Technologies) was used for
fluorescence acquisition and Cq calculation. For this cal-
culation, the baseline was set automatically and the
fluorescence threshold was set manually (0.1) to inter-
sect with the linear part of the amplification curves of all
of the amplicons in all of the runs. For the statistical
analysis, the relative quantification approach was used
[60]. The geometric means of the Cq values of all of the
reference genes were used as the final reference gene
values [61]. Relative expression was calculated separately
for each dilution of each sample, and averaged, to yield
the final relative expression for the samples. Welch two-
tailed t-tests [62] were used to determine the statistically
significant differences between the relative expression
ratios of each transgene in the stable and unstable sam-
ples, with corrected P = 0.05 as the limit for statistical
significance.
The copy numbers of each recombinant gene were cal-
culated using the absolute quantification method. A
standard curve was constructed using the DNA of the
same expressed vector as was used for the transfection
of the host cell line and gDNA of the parental CHO-
der1 derived host cell line. The Cq calculations were
performed as described above. The copy numbers of the
recombinant gene and endogenous gene (Gluc, Glucagon
gene) in the samples were extrapolated from the standard
Table 1 List of the primers and probes of the reference genes used in the RT-qPCR analysis
Gene Name Forward Primer (5′→ 3′) Reverse Primer (5′→ 3′) Probe (5′→ 3′)
Reference gene for copy number
Glucagon (Gluc) ATTGCCAAACGCCACGAT CCAAGCAATGAATTCCTTTGC CTGAAGGGACCTTTACCA
Reference genes for gene expression
Actb AGCCACGCTCGGTCAG CATCCTGCGTCTGGACCT CCGGGACCTGACAGACT
Gapdh TCAACGGGAAGGCCATCAC CCATTTGATGTTGGCGGGATC TCGCTCCTGGAAGATG
Transgene
rDhfr ATATGGGGATTGGCAAGAACG CATTCTTTGGAAGTACTTGAACTCGTT AGACCGACCCTGGC
The reference genes were used for the copy number and gene expression calculations. All of the primers and probes were designed as TaqMan Gene Expression
Assays labelled with FAM (3′) and MGB (5′). The sequence of the recombinant gene is confidential
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curves. The ratios between the endogenous gene Gluc
(single copy gene) and the recombinant gene were calcu-
lated, to determine the transgene copy numbers per cell.
PCA analysis and three-dimensional representation
The properties of the clones described by the expression
of the five most specifically expressed genes between
the stable and unstable samples were visualised in
MATLAB2014 (The Mathworks Inc.). Principal com-
ponent analysis was performed on the expression data
(RT-qPCR data) of the five most differently expressed
genes which were not affected by MTX, and the three
most significant principal components are presented three
dimensions [63]. To systematically evaluate the separation
of the stable and unstable clones, the k-nearest neighbour
clustering algorithm was used for the three-dimensional
representation [64]. This algorithm uses unsupervised
learning, where the goal is to separate the data into a pre-
defined number of clusters, while no information on clus-
ter membership of each training sample is provided. The
algorithm minimizes the sum of the squared Euclidian dis-
tances between the members and the centroids of the
clusters. The algorithm clusters the data into a number of
predefined clusters, where no information on cluster
membership is provided in advance. An optimal number
of clusters can be identified by observing the total sum of
all of the sample distances to the cluster centres. The opti-
mal number of clusters is found by analysing a curve de-
fined by the total sum of distances versus the number of
clusters. A distinctive change in a slope in the curve de-
fines the optimal number of clusters. As a result, the most
likely class centroids and its members are estimated. The
rate of correctly classified samples was taken as a measure
for the separation of the stable and unstable groups on the
basis of the gene expression data of five genes. The k-
means function of MATLAB2014 (The Mathworks Inc.)
was used for this task.
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E130203B14 CCAGTGGGTACATCACATGAGAGA CCCGAGTGGGAGCTGACT AAACTGTGCCAAACTC
hDhfr ATATGGGGATTGGCAAGAACG CATTCTTTGGAAGTACTTGAACTCGTT AGACCTACCCTGGCCT
Hist1h2bc ACGAGGAGTAGACCTGATGATGT GTATCACCTATTTCCATTGTCTCAATTGC CAGTGCTGGACGTTGTT
Cspg4 GCCATGTGGCCTAGCTTCAT AAACAGGTGAGAATAGAGGACTTTGG CAAGCTCTTGAATTCC
C1qtnf1 CATTCCACAGACACTGGATGGA GCCAAAGAAGCCAGGACTGA CTGACCCCATCATCCC
Foxp2 GGGCTTACGGCTTATACTCTATGTG CCCAGTTAGTGGTAATTCTATCAAGTACTTT ACGGTGCCATGAATCC
Mmp10 CAGGAATCGAGCCACAAATTGATG TCAAACTGTGATGATCCATGGAAGAA AATGCCTGCAACACCG
Vsnl1 ACCCTTAAGCATATGTCTTTGGAATTTGA TTCCGAAATGAACAAATCGTCTGTT TCATCCAGCCCCTCCC
CU459186.1 GGGAGGCCGGTTTTGG TTGTGCAACACCCAGAGACTAC TTGCTGCCCGGTATCC
Egr1 GCTCACCTCTGGCCTTAAAGG CATTCTGGAGAACCAAAGCT CAGCTCAGCCCTCTTC
Ptpre CCCTCCAGTCTCTTGGCTAATG GCAAACTGAGTCTCTGTGTCTTAGG CCACAACCAAATTCAG
All of the primers and probes were designed as TaqMan Gene Expression Assays labelled with FAM (3′) and MGB (5′)
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